Literature DB >> 23609145

Inhibition of the proton-coupled folate transporter (PCFT-SLC46A1) by bicarbonate and other anions.

Rongbao Zhao1, Michele Visentin, Sylvia O Suadicani, I David Goldman.   

Abstract

The proton-coupled folate transporter (PCFT) plays a key role in intestinal folate absorption, and loss-of-function mutations in the gene encoding this transporter are the molecular basis for hereditary folate malabsorption. Using a stable transfectant with high expression of PCFT, physiologic levels of bicarbonate produced potent and rapidly reversible inhibition of PCFT-mediated transport at neutral pH. Bisulfite and nitrite also inhibited PCFT function at neutral pH, whereas sulfate, nitrate, and phosphate had no impact at all. At weakly acidic pH (6.5), bisulfite and nitrite exhibited much stronger inhibition of PCFT-mediated transport, whereas sulfate and nitrate remained noninhibitory. Inhibition by bisulfite and nitrite at pH 6.5 was associated with a marked decrease in the influx Vmax and collapse of the transmembrane proton gradient attributed to the diffusion of the protonated forms into these cells. Monocarboxylates such as pyruvate and acetate also collapsed the pH gradient and were also inhibitory, whereas citrate and glycine neither altered the proton gradient nor inhibited PCFT-mediated transport. These observations add another dimension to the unfavorable pH environment for PCFT function in systemic tissues: the presence of high concentrations of bicarbonate.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23609145      PMCID: PMC3684825          DOI: 10.1124/mol.113.085605

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  28 in total

1.  Addition of bisulfite to folate and dihydrofolate.

Authors:  D J Vonderschmitt; K S Vitols; F M Huennekens; K G Scrimgeour
Journal:  Arch Biochem Biophys       Date:  1967-11       Impact factor: 4.013

2.  Structural requirements for anion substrates of the methotrexate transport system in L1210 cells.

Authors:  G B Henderson; E M Zevely
Journal:  Arch Biochem Biophys       Date:  1983-03       Impact factor: 4.013

3.  Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells.

Authors:  R Zhao; F Gao; Y Wang; G A Diaz; B D Gelb; I D Goldman
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

4.  Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.

Authors:  Yanhua Wang; Rongbao Zhao; I David Goldman
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

5.  The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1.

Authors:  Ersin Selcuk Unal; Rongbao Zhao; Min-Hwang Chang; Andras Fiser; Michael F Romero; I David Goldman
Journal:  J Biol Chem       Date:  2009-04-23       Impact factor: 5.157

Review 6.  The relevance of tumour pH to the treatment of malignant disease.

Authors:  J L Wike-Hooley; J Haveman; H S Reinhold
Journal:  Radiother Oncol       Date:  1984-12       Impact factor: 6.280

7.  A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier.

Authors:  Rongbao Zhao; Feng Gao; Marie Hanscom; I David Goldman
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

8.  Influence of 2,3-diphosphoglycerate metabolism on sodium-potassium permeability in human red blood cells: studies with bisulfite and other redox agents.

Authors:  J C Parker
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

9.  Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathway.

Authors:  Rongbao Zhao; Marie Hanscom; Shrikanta Chattopadhyay; I David Goldman
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

10.  Interaction between anions and the reduced folate/methotrexate transport system in L1210 cell plasma membrane vesicles: directional symmetry and anion specificity for differential mobility of loaded and unloaded carrier.

Authors:  C H Yang; F M Sirotnak; M Dembo
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

View more
  12 in total

Review 1.  The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption.

Authors:  Rongbao Zhao; Srinivas Aluri; I David Goldman
Journal:  Mol Aspects Med       Date:  2016-09-21

Review 2.  The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.

Authors:  Larry H Matherly; Zhanjun Hou; Aleem Gangjee
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-10       Impact factor: 3.333

Review 3.  The proton-coupled folate transporter: physiological and pharmacological roles.

Authors:  Rongbao Zhao; I David Goldman
Journal:  Curr Opin Pharmacol       Date:  2013-12       Impact factor: 5.547

Review 4.  The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.

Authors:  Larry H Matherly; Mike R Wilson; Zhanjun Hou
Journal:  Drug Metab Dispos       Date:  2014-01-06       Impact factor: 3.922

5.  Concentrative Transport of Antifolates Mediated by the Proton-Coupled Folate Transporter (SLC46A1); Augmentation by a HEPES Buffer.

Authors:  Rongbao Zhao; Mitra Najmi; Srinivas Aluri; David C Spray; I David Goldman
Journal:  Mol Pharmacol       Date:  2018-01-11       Impact factor: 4.436

Review 6.  Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.

Authors:  Zhanjun Hou; Larry H Matherly
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

Review 7.  The intestinal absorption of folates.

Authors:  Michele Visentin; Ndeye Diop-Bove; Rongbao Zhao; I David Goldman
Journal:  Annu Rev Physiol       Date:  2014       Impact factor: 19.318

8.  Enhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expression.

Authors:  Rongbao Zhao; Ndeye Diop-Bove; I David Goldman
Journal:  Mol Pharmacol       Date:  2013-11-18       Impact factor: 4.436

9.  The Key Role of Purine Metabolism in the Folate-Dependent Phenotype of Autism Spectrum Disorders: An In Silico Analysis.

Authors:  Jan Geryk; Daniel Krsička; Markéta Vlčková; Markéta Havlovicová; Milan Macek; Radka Kremlíková Pourová
Journal:  Metabolites       Date:  2020-05-06

Review 10.  Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.

Authors:  Aamod S Dekhne; Zhanjun Hou; Aleem Gangjee; Larry H Matherly
Journal:  Mol Cancer Ther       Date:  2020-09-02       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.